Chiron, SourceCF Settle Inhaler Lawsuit

Biotechnology company Chiron said that it settled a suit against a licenser of cystic fibrosis products that will require the company, SourceCF, to attach a warning label on promotional materials for an electronic inhaler. Chiron had charged in an October lawsuit that a group of companies established by SourceCF illegally promoted the eFlow inhaler for use with tobramycin, an antibiotic used to treat lung infections from cystic fibrosis.

Forbes (http://www.forbes.com/home/feeds/ap/2005/03/04/ap1864361.html)